converts coclaurine to N-methylcoclaurine in isoquinoline alkaloid biosynthesis. The N-terminal amino acid sequence of Coptis CNMT was used to amplify the corresponding cDNA fragment, and later to isolate full-length cDNA using 5'-and 3'-RACE. The nucleotide sequence and predicted amino acid sequence showed that the cDNA encoded 358 amino acids which contained a putative S-adenosyl-L-methionine binding domain and showed relatively high homology to tomato phosphoethanolamine-N-methyltransferase. Recombinant protein was expressed in E. coli and its CNMT activity was confirmed. Recombinant CNMT was purified to homogeneity and enzymological characterization confirmed that Coptis CNMT has quite broad substrate specificity; i.e. not only for 6-O-methylnorlaudanosoline and norreticuline but also for 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline. The evolution of Nmethyltransferases in secondary metabolism is discussed based on sequence similarity.
Based on this observation, we determined the N-terminal amino acids, isolated the corresponding cDNA fragment, and finally the full-length cDNA. The nucleotide sequence of cDNA suggested that the deduced amino acid sequence showed some similarity to known NMTs such as phosphoethanolamine NMT. Further characterization of recombinant protein heterologously expressed in Escherichia coli confirmed that this isolated cDNA encoded CNMT. Recombinant CNMT was purified to homogeneity and its enzymological properties were characterized. The evolution of CNMT involved in secondary metabolism is discussed based on the sequence similarity of this novel NMT.
Experimental Procedures:
Plant material-Cultured Coptis japonica cells with high berberine productivity were maintained as described previously (15). Ten-day-old cultured cells were harvested and used for the extraction of mRNA. Amino acid sequence analysis-To determine N-terminal amino acid sequences, 100 µg of a preparation of purified CNMT (1) was electrotransferred on a polyvinylidene difluoride (PVDF) membrane (Nihon Milipore, Yonezawa, Japan) from a gel after sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as described elsewhere (9) . A protein band of 45 kDa with slower mobility than an accompanying band was cut from the PVDF membrane and the amino acid sequence of the peptide was determined with a protein sequencer (model 477A/120A; Applied Biosystems).
Chemicals-
library was constructed according to the method of Gubler and Hoffman (17). In brief, the first strand of cDNA was synthesized using 3 µg of poly(A)+ RNA, oligo (dT) linker-primer, RAV-2 reverse transcriptase (Stratagene), and SuperScript II reverse transcriptase (Stratagene). After the second strand of cDNA was synthesized, blunt-end adaptor containing the EcoR I-Not I-BamH I restriction site was ligated into synthesized cDNA, and the cDNA fragments were then ligated into pDR196 vector (18). 
Purification of recombinant CNMT from E. coli lysate-Large
amounts of recombinant CNMT were produced in 600 ml culture of E.
coli. Unless otherwise noted, CNMT was purified as described previously (1) . In brief, CNMT was purified by Phenyl Sepharose, Q- 
Results:
Isolation of cDNA for CNMT-In our previous report (1), we purified CNMT 340-fold from cultured Coptis cells, but this highly purified fraction still contained two protein bands. Based on a detailed analysis of the chromatographic elution profile and enzyme activity, we estimated that the slow-moving polypeptide should correspond to CNMT. To obtain molecular information on CNMT, purified CNMT was blotted on PVDF membranes and its N-terminal amino acid sequence was determined. These 33 amino acids were determined to be as shown in Fig. 2 .
Since several attempts to isolate full-length cDNA with degenerated primers designed for this N-terminal sequence failed, we tried to amplify the corresponding cDNA for this N-terminal amino acid sequence.
Primers were designed based on the codon usage predicted from known
Coptis genes (4, 9) and cDNA was amplified under conditions of rather low stringency. cDNA fragments of a corresponding length (ca 100 bp)
were amplified, subcloned and sequenced. The nucleotide sequences of these amplified fragments indicated that a predicted amino acid sequence of a clone corresponded to the determined N-terminal sequence of CNMT (data not shown).
Based on the nucleotide sequence determined in a cloned PCR fragment, strict complementary primers were designed to obtain almost a full-length 3'-fragment of CNMT. The amplified fragment (1.3 kb)
was subcloned into pGEM-T vector and sequenced. The amino acid sequence predicted from the determined nucleotide sequence showed the presence of a putative AdoMet binding domain, which indicated that the correct sequence was amplified. A 5'-fragment of CNMT was obtained by 5'-RACE using an internal nucleotide sequence in the 3'-fragment of CNMT. After the sequence of this 5'-fragment was determined, fulllength cDNA was re-cloned from the cDNA library using UESP and UEAP primers, and the nucleotide sequence was confirmed. (Fig. 3) .
Expression of the recombinant polypeptide in E. coli and its CNMT
activity-Its amino acid sequence suggested that isolated cDNA would encode CNMT of Coptis. To confirm the identity of this clone, recombinant protein was produced in E. coli and enzyme activity was determined. Enzyme assay with the crude E. coli lysate clearly showed that the enzyme extract prepared from E. coli expressing pCJCNMT1 had methylation activity for norreticuline (data not shown), whereas the extract of E. coli carrying the control pET-21d vector showed no enzymatic activity. Further LC-MS analysis confirmed that recombinant CNMT formed reticuline from norreticuline in the presence of AdoMet (Fig. 4) . These results indicated that the isolated clone correctly encodes
Coptis CNMT. Partially truncated CNMT was also produced to examine the importance of the N-terminal sequence. This 15-amino acid deletion did not change the enzyme activity, whereas the protein was not purified and the specific activity was not determined.
Purification of recombinant CNMT and its characterization-Since
CNMT purified from cultured Coptis cells was not homogeneous, we purified recombinant CNMT to homogeneity and characterized its enzymological properties. Recombinant CNMT was successfully purified to homogeneity from E. coli lysate only after 3 column chromatographies but at a 5-fold higher yield than from cultured Coptis cells (Table 1 , Fig. 5 ). Finally, purified recombinant CNMT showed much higher specific activity than native CNMT purified from Coptis cells, probably due to the high expression in transformed E. coli and the following rapid purification. Full-length CNMT was hydrophilic, as predicted from a hydropathy plot (data not shown).
Since the specific activity was considerably different, we re- Substrate specificity of recombinant CNMT-Previously, we found that Coptis CNMT had relatively broad substrate specificity. Since heterologous expression in E. coli provided a sufficient amount of recombinant enzyme, we examined the substrate specificity. The
incorporation of radioactivity from S-adenosyl-L-[methyl-3 H]
methionine to the products was used to determine substrate specificity.
When norreticuline was the control substrate (i.e. relative incorporation reported previously. Recombinant CNMT methylated 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline as much as coclaurine and the methylation product was confirmed by LC-MS (data not shown, Table   2 ). However, the methylation of 1,2,3,4-tetrahydroisoquinoline, tryptamine, and purine was not detected either by measuring radioactivity incorporation or by HPLC analysis (data not shown).
Discussion:
Based on the N-terminal amino acid sequence of purified CNMT and information on codon usage in Coptis genes, a full-length cDNA encoding CNMT was successfully cloned and its enzymatic activity was confirmed in a heterologous expression system. Recombinant CNMT purified from transgenic E. coli showed a significantly higher activity than that of CNMT purified from cultured Coptis cells. CNMT deduced from the cDNA sequence was 358 amino acids long, with a calculated molecular mass of 41 kDa, which was slightly lower than the apparent molecular mass (45 kDa) of purified CNMT determined by SDS-PAGE.
SDS-PAGE analysis of purified recombinant CNMT revealed a similar mobility for CNMT purified from Coptis cells, indicating that this discrepancy between calculated molecular mass and apparent molecular mass was not due to post-translational modification, but rather to experimental variation, probably associated with the surface charge or conformation of CNMT.
Since this CNMT sequence was the first reported NMT sequence in isoquinoline alkaloid biosynthesis and the third reported NMT in alkaloid biosynthesis in plants (13, 14) , the sequences of these plant alkaloid NMTs and other methyltransferases were compared to get more information about the diversity of methyltransferases. Whereas several plant O-methyltransferases have relatively high sequence homology, ranging from 32 to 71 %, the diversity of N-methyltransferases is quite high (Fig. 3) ; the sequence identity among NMTs is about 5-15 %. This means that each NMT may have evolved from an independent origin.
CNMT showed relatively high homology to a hypothetical Arabidopsis Thin arrows (5RAP1, 5RAP2) indicate the sense primers for 5'RACE.
Asterisk shows the stop codon. Motif A, a conserved sequence motif in plant AdoMet-dependent methyltransferase, is shadowed. Fig. 3 Phylogenic tree of N-and O-methyltransferases. Amino acid sequences obtained from GenBank TM were used for tree building. Nine sequences were aligned by the multisequence alignment program in GENETYX-MAX Ver.11
(Software Development Inc., Japan) using the UPGMA (unweighted pair group maximum average) method. Fig.1 
